Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF

Circulation. 2021 Jul 13;144(2):180-182. doi: 10.1161/CIRCULATIONAHA.121.054034. Epub 2021 Jul 12.
No abstract available

Keywords: defibrillators, implantable; heart failure; sacubitril-valsartan; stroke volume.

Publication types

  • Letter